Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

Uttpal Anand; Abhijit Dey; Arvind K. Singh Chandel; Rupa Sanyal; Amarnath Mishra; Devendra Kumar Pandey; Valentina De Falco; Arun Upadhyay; Ramesh Kandimalla; Anupama Chaudhary; Jaspreet Kaur Dhanjal; Saikat Dewanjee; Jayalakshmi Vallamkondu; José M. Pérez de la Lastra

doi:10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, Rupa Sanyal, Amarnath Mishra, Devendra Kumar Pandey, Valentina De Falco, Arun Upadhyay, Ramesh Kandimalla, Anupama Chaudhary, Jaspreet Kaur Dhanjal, Saikat Dewanjee, Jayalakshmi Vallamkondu, José M. Pérez de la Lastra

Zuckerberg Institute for Water Research

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

Original language	English
Article number	101211
Journal	Genes and Diseases
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/j.gendis.2024.101211
State	Published - 1 Jul 2024

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Genetics(clinical)
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.gendis.2024.101211

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]'. Together they form a unique fingerprint.

Cite this

Anand, U., Dey, A., Singh Chandel, A. K., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., Dhanjal, J. K., Dewanjee, S., Vallamkondu, J., & Pérez de la Lastra, J. M. (2024). Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]. Genes and Diseases, 11(4), Article 101211. https://doi.org/10.1016/j.gendis.2024.101211

@article{9d7f90516a614d38b4292e50157bffc6,

title = "Corrigendum to {\textquoteleft}Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics{\textquoteright} [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]",

abstract = "In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.",

author = "Uttpal Anand and Abhijit Dey and {Singh Chandel}, {Arvind K.} and Rupa Sanyal and Amarnath Mishra and Pandey, {Devendra Kumar} and {De Falco}, Valentina and Arun Upadhyay and Ramesh Kandimalla and Anupama Chaudhary and Dhanjal, {Jaspreet Kaur} and Saikat Dewanjee and Jayalakshmi Vallamkondu and {P{\'e}rez de la Lastra}, {Jos{\'e} M.}",

note = "Publisher Copyright: {\textcopyright} 2024 Chongqing Medical University",

year = "2024",

month = jul,

day = "1",

doi = "10.1016/j.gendis.2024.101211",

language = "English",

volume = "11",

journal = "Genes and Diseases",

issn = "2352-4820",

publisher = "KeAi Communications Co.",

number = "4",

}

Anand, U, Dey, A, Singh Chandel, AK, Sanyal, R, Mishra, A, Pandey, DK, De Falco, V, Upadhyay, A, Kandimalla, R, Chaudhary, A, Dhanjal, JK, Dewanjee, S, Vallamkondu, J & Pérez de la Lastra, JM 2024, 'Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]', Genes and Diseases, vol. 11, no. 4, 101211. https://doi.org/10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]. / Anand, Uttpal; Dey, Abhijit; Singh Chandel, Arvind K. et al.
In: Genes and Diseases, Vol. 11, No. 4, 101211, 01.07.2024.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to ‘Cancer chemotherapy and beyond

T2 - Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

AU - Anand, Uttpal

AU - Dey, Abhijit

AU - Singh Chandel, Arvind K.

AU - Sanyal, Rupa

AU - Mishra, Amarnath

AU - Pandey, Devendra Kumar

AU - De Falco, Valentina

AU - Upadhyay, Arun

AU - Kandimalla, Ramesh

AU - Chaudhary, Anupama

AU - Dhanjal, Jaspreet Kaur

AU - Dewanjee, Saikat

AU - Vallamkondu, Jayalakshmi

AU - Pérez de la Lastra, José M.

PY - 2024/7/1

Y1 - 2024/7/1

N2 - In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

AB - In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

UR - http://www.scopus.com/inward/record.url?scp=85189036657&partnerID=8YFLogxK

U2 - 10.1016/j.gendis.2024.101211

DO - 10.1016/j.gendis.2024.101211

M3 - Comment/debate

C2 - 38572324

AN - SCOPUS:85189036657

SN - 2352-4820

VL - 11

JO - Genes and Diseases

JF - Genes and Diseases

IS - 4

M1 - 101211

ER -

Anand U, Dey A, Singh Chandel AK, Sanyal R, Mishra A, Pandey DK et al. Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]. Genes and Diseases. 2024 Jul 1;11(4):101211. doi: 10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this